Aster DM Healthcare Limited
NSE:ASTERDM.NS
416.7 (INR) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 36,989 | 119,328.8 | 102,532.8 | 86,084.3 | 87,385 | 79,627.1 | 67,211.61 | 59,312.87 | 52,498.9 | 38,758.43 | 28,711.45 | 19,217.42 |
| Cost of Revenue
| 26,514.6 | 35,318.2 | 29,089.6 | 25,606.4 | 33,855.1 | 30,648.5 | 26,136.6 | 18,873.27 | 16,231.49 | 12,221.71 | 18,191.76 | 11,931.16 |
| Gross Profit
| 10,474.4 | 84,010.6 | 73,443.2 | 60,477.9 | 53,529.9 | 48,978.6 | 41,075.01 | 40,439.6 | 36,267.41 | 26,536.72 | 10,519.69 | 7,286.26 |
| Gross Profit Ratio
| 0.283 | 0.704 | 0.716 | 0.703 | 0.613 | 0.615 | 0.611 | 0.682 | 0.691 | 0.685 | 0.366 | 0.379 |
| Reseach & Development Expenses
| 0 | 144.8 | 45.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 8,156.2 | 10,383.4 | 9,462.8 | 7,582.6 | 639.1 | 597 | 565.5 | 5,629.26 | 4,379.53 | 3,186.85 | 915.8 | 682.05 |
| Selling & Marketing Expenses
| -1,261.6 | 2,037.2 | 1,372.9 | 789.9 | 998.6 | 967.5 | 1,197.31 | 1,461.66 | 975.04 | 544.03 | 305.18 | 203.88 |
| SG&A
| 6,894.6 | 10,383.4 | 10,835.7 | 8,372.5 | 1,637.7 | 1,564.5 | 1,762.81 | 7,090.92 | 5,354.57 | 3,730.88 | 1,220.98 | 885.93 |
| Other Expenses
| 248.5 | 76.1 | -2,098.4 | -2,304.4 | 308 | 223.6 | 35,504.33 | 285.99 | 165.89 | 76.95 | 0 | 0 |
| Operating Expenses
| 6,894.6 | 75,455.9 | 61,958.3 | 52,699 | 46,496.3 | 43,143.1 | 37,267.14 | 40,134.64 | 33,966.13 | 22,783.37 | 7,050.25 | 5,410.09 |
| Operating Income
| 3,579.8 | 7,861.8 | 8,439.3 | 4,475.1 | 6,771 | 5,835.5 | 3,937.97 | 304.96 | 2,301.28 | 3,753.35 | 3,452.82 | 1,920.68 |
| Operating Income Ratio
| 0.097 | 0.066 | 0.082 | 0.052 | 0.077 | 0.073 | 0.059 | 0.005 | 0.044 | 0.097 | 0.12 | 0.1 |
| Total Other Income Expenses Net
| -854.5 | -2,511 | -2,070.8 | -2,424.6 | -3,470.6 | -1,733 | -860.34 | 2,580.38 | -1,924.99 | -690.74 | -348.72 | -375.54 |
| Income Before Tax
| 2,725.3 | 5,350.8 | 6,368.5 | 2,050.5 | 3,300.4 | 4,102.5 | 3,077.63 | 2,885.34 | 376.29 | 3,062.61 | 3,104.1 | 1,545.14 |
| Income Before Tax Ratio
| 0.074 | 0.045 | 0.062 | 0.024 | 0.038 | 0.052 | 0.046 | 0.049 | 0.007 | 0.079 | 0.108 | 0.08 |
| Income Tax Expense
| 565.1 | 595.9 | 358 | 272.2 | 153.8 | 429.4 | 260.82 | 217.87 | 294.18 | 341.54 | 267.18 | 55.28 |
| Net Income
| 1,292.8 | 4,249.1 | 5,259.9 | 1,477.4 | 2,766.1 | 3,331.1 | 2,688.76 | 1,986.98 | -590.15 | 1,326.92 | 1,777.83 | 917.81 |
| Net Income Ratio
| 0.035 | 0.036 | 0.051 | 0.017 | 0.032 | 0.042 | 0.04 | 0.033 | -0.011 | 0.034 | 0.062 | 0.048 |
| EPS
| 2.6 | 8.54 | 10.58 | 2.97 | 5.51 | 6.63 | 5.75 | 2.2 | -1.26 | 2.83 | 4.73 | 2.44 |
| EPS Diluted
| 2.6 | 8.53 | 10.57 | 2.97 | 5.5 | 6.62 | 5.74 | 2.19 | -1.26 | 2.83 | 4.73 | 2.44 |
| EBITDA
| 5,779.5 | 16,447.4 | 15,315.3 | 11,289.5 | 12,493.4 | 8,756.9 | 6,915.41 | 3,185.88 | 4,545.37 | 5,153.51 | 4,554.6 | 2,672.85 |
| EBITDA Ratio
| 0.156 | 0.138 | 0.149 | 0.131 | 0.143 | 0.11 | 0.103 | 0.054 | 0.087 | 0.133 | 0.159 | 0.139 |